In yesterday’s Wall Street session, Edwards Lifesciences Corp (NYSE:EW) shares traded at $59.70, down -31.34% from the previous session.
EW stock price is now -32.91% away from the 50-day moving average and -26.89% away from the 200-day moving average. The market capitalization of the company currently stands at $35.98B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target reduced from $110 to $82, Truist Downgraded its rating from Buy to Hold for Edwards Lifesciences Corp (NYSE: EW). On July 26, 2024, TD Cowen Downgraded its previous ‘Buy’ rating to ‘Hold’ on the stock reducing its target price from $100 to quote $70, while ‘Robert W. Baird’ rates the stock as ‘Neutral’
In other news, Lippis Daniel J., CVP, JAPAC sold 500 shares of the company’s stock on Jul 11 ’24. The stock was sold for $47,090 at an average price of $94.18. Upon completion of the transaction, the CVP, JAPAC now directly owns 23,189 shares in the company, valued at $1.38 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jul 10 ’24, CVP,Strategy/Corp Development BOBO DONALD E JR sold 5,000 shares of the business’s stock. A total of $466,474 was realized by selling the stock at an average price of $93.29. This leaves the insider owning 46,936 shares of the company worth $2.8 million. A total of 1.60% of the company’s stock is owned by insiders.
During the past 12 months, Edwards Lifesciences Corp has had a low of $60.57 and a high of $96.12. As of last week, the company has a debt-to-equity ratio of 0.09, a current ratio of 3.71, and a quick ratio of 2.87. According to the stock market information, the enterprise value for the company is $34715770880, which is based on a 24.57 price-to-earnings ratio, a 2.29 price-to-earnings-growth ratio, and a beta of 1.12. The fifty day moving average price for EW is $88.4898 and a two-hundred day moving average price translates $81.5853 for the stock.
The latest earnings results from Edwards Lifesciences Corp (NYSE: EW) was released for 2024-06-30. The net profit margin was 24.55% and return on equity was 21.35% for EW. The company reported revenue of $1.6 billion for the quarter, compared to $1.46 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 9.5 percent.
